What Happened?
A number of stocks jumped in the afternoon session after a surge in investment banking and trading revenues drove strong second-quarter earnings for the big banks.
Major financial institutions are benefiting from what JPMorgan's CFO described as a "booming environment" for dealmaking. Revenue from advising on mergers and acquisitions (M&A) and initial public offerings (IPOs) surged, with fees reaching their highest levels since 2021. This uptick in activity signaled the most bullish environment for deals in years. For example, Goldman Sachs saw its profit exceed expectations, partly due to a pickup in dealmaking, which lifted its stock. This trend suggests a robust appetite for corporate transactions and capital raising across the market.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Investment Banking & Brokerage company Moelis (NYSE: MC) jumped 4.4%. Is now the time to buy Moelis? Access our full analysis report here, it’s free.
- Investment Banking & Brokerage company Lazard (NYSE: LAZ) jumped 5%. Is now the time to buy Lazard? Access our full analysis report here, it’s free.
Zooming In On Lazard (LAZ)
Lazard’s shares are somewhat volatile and have had 11 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 5 days ago when the stock gained 4.4% on the news that it was announced as the financial advisor to Warburg Pincus on a $3.6 billion private equity transaction.
An important number from the announcement is the $3.6 billion valuation attached to Warburg Pincus's $130 million investment in data infrastructure provider Oxylabs. Lazard generates its core revenue from Financial Advisory fees, and securing mandates on multi-billion-dollar sponsor deals fuels top-line growth.
More importantly, this specific mandate serves as a broader bellwether for the firm's pipeline. However, investors should keep in mind that investment banking revenue is inherently lumpy. A single prominent mandate provides excellent short-term sentiment momentum, but it does not guarantee a sustained, structural rebound in aggregate M&A volumes ahead of Lazard's upcoming Q2 earnings report later this month.
Lazard is down 12.8% since the beginning of the year, and at $43.37 per share, it is trading 24.9% below its 52-week high of $57.75 from August 2025. Investors who bought $1,000 worth of Lazard’s shares 5 years ago would now be looking at only $964.95.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
